Changes of serum albumin level and systemic inflammatory response in inoperable non-small cell lung cancer patients after chemotherapy | Zendy

Xiaomei Yao | Zendy; Xinsheng Wang | Zendy; Hongli Han | Zendy; Qi Duan | Zendy; Uzair Athar Khan | Zendy; Yong-Hao Hu | Zendy

Open Access

Changes of serum albumin level and systemic inflammatory response in inoperable non-small cell lung cancer patients after chemotherapy

Author(s) -

Xiaomei Yao,

Xinsheng Wang,

Hongli Han,

Qi Duan,

Uzair Athar Khan,

Yong-Hao Hu

Publication year - 2014

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.137953

Subject(s) - hypoalbuminemia , medicine , chemotherapy , albumin , gastroenterology , lung cancer , serum albumin , toxicity , cancer

Hypoalbuminemia and systemic inflammatory response (SIR) parameters are a key role in the prognosis of cancer patients. We aim to investigate the changes of serum albumin level and SIR after chemotherapy, in patients with inoperable non-small cell lung cancer (NSCLC). The hypothesis is that improved serum albumin level may be beneficial to the SIR parameters and will reduce chemotherapy-induced toxicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research